<?xml version="1.0" ?>
<document id="29322514">
  <sentence id="29322514.s0" text="A growing body of literature indicates that YY1 is overexpressed in multiple cancer muscle organ developments and that increased YY1 levels correlate with poor clinical outcomes in many cancers.">
    <entity charOffset="77-83" id="29322514.s0.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-108" id="29322514.s0.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="29322514.s0.e0" e2="29322514.s0.e1" id="29322514.s0.p0" relation="false"/>
  </sentence>
  <sentence id="29322514.s1" text="However, the role of YY1 in the promotion or suppression of tumor growth remains controversial and its regulatory effects may be tumor cell muscle organ development dependent at least in experimental systems.">
    <entity charOffset="60-65" id="29322514.s1.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-164" id="29322514.s1.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="29322514.s1.e0" e2="29322514.s1.e1" id="29322514.s1.p0" relation="false"/>
  </sentence>
  <sentence id="29322514.s2" text="This review highlights recent advances in our understanding of regulatory insights involving YY1 function in a range of cancer muscle organ developments.">
    <entity charOffset="120-126" id="29322514.s2.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-151" id="29322514.s2.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="29322514.s2.e0" e2="29322514.s2.e1" id="29322514.s2.p0" relation="false"/>
  </sentence>
  <sentence id="29322514.s3" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1Î± in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular regulation of cell growth and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving negative regulation of T cell mediated cytotoxicity, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="29322514.s3.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="251-276" id="29322514.s3.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="458-509" id="29322514.s3.e2" ontology_id="GO_0001915" text="negative regulation of T cell mediated cytotoxicity" type="GO"/>
    <pair e1="29322514.s3.e0" e2="29322514.s3.e1" id="29322514.s3.p0" relation="false"/>
    <pair e1="29322514.s3.e0" e2="29322514.s3.e2" id="29322514.s3.p1" relation="false"/>
  </sentence>
  <sentence id="29322514.s4" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased B cell apoptotic process transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of osteoblast differentiation overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="29322514.s4.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-158" id="29322514.s4.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="170-194" id="29322514.s4.e2" ontology_id="GO_0001783" text="B cell apoptotic process" type="GO"/>
    <entity charOffset="429-455" id="29322514.s4.e3" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="29322514.s4.e0" e2="29322514.s4.e1" id="29322514.s4.p0" relation="true"/>
    <pair e1="29322514.s4.e0" e2="29322514.s4.e2" id="29322514.s4.p1" relation="false"/>
    <pair e1="29322514.s4.e0" e2="29322514.s4.e3" id="29322514.s4.p2" relation="true"/>
  </sentence>
  <sentence id="29322514.s5" text="YY1 expression is associated with that of cancer stem cell markers osteoblast differentiation, positive regulation of ubiquitin-protein transferase activity and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="29322514.s5.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-93" id="29322514.s5.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="95-156" id="29322514.s5.e2" ontology_id="GO_0051443" text="positive regulation of ubiquitin-protein transferase activity" type="GO"/>
    <pair e1="29322514.s5.e0" e2="29322514.s5.e1" id="29322514.s5.p0" relation="true"/>
    <pair e1="29322514.s5.e0" e2="29322514.s5.e2" id="29322514.s5.p1" relation="false"/>
  </sentence>
</document>
